Home › Funds › DAVENPORT & Co LLC › ELV
DAVENPORT & Co LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
DAVENPORT & Co LLC reported holding 384,435 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$150.0M, representing 0.95% of its reported portfolio and ranking #19 among its reported holdings. DAVENPORT & Co LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR
How DAVENPORT & Co LLC's ELV position evolved
DAVENPORT & Co LLC first disclosed a stake in ELV in Q3 2023 at 250,073 shares (US$109.6M). The position peaked in Q3 2025 at 630,203 shares, worth US$203.0M. Across 13 filings, DAVENPORT & Co LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 384,435 shares valued at US$150.0M — a reduction of -57,505 shares quarter over quarter.. Notable position changes include a 128% increase in Q3 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 250.07K | $109.58M | New |
| Q4 2023 | 248.96K | $117.23M | Hold |
| Q1 2024 | 244.57K | $126.90M | Reduce |
| Q2 2024 | 243.40K | $131.55M | Hold |
| Q3 2024 | 183.56K | $95.60M | Reduce |
| Q4 2024 | 228.06K | $84.13M | Add |
| Q1 2025 | 281.87K | $122.42M | Add |
| Q2 2025 | 276.45K | $107.06M | Reduce |
| Q3 2025 | 630.20K | $203.05M | Add |
| Q4 2025 | 575.78K | $201.55M | Reduce |
| Q1 2026 | 574.01K | $166.76M | Hold |
| Q2 2026 | 441.94K | $171.10M | Reduce |
| Q3 2026 | 384.44K | $149.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on DAVENPORT & Co LLC
FAQ
How long has DAVENPORT & Co LLC held ELV?
DAVENPORT & Co LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DAVENPORT & Co LLC's current position in ELV?
As of Q3 2026, DAVENPORT & Co LLC holds 384.44K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $149.99M, representing 0.95% of its reported portfolio and ranking #19.
Has DAVENPORT & Co LLC been buying or selling ELV?
In the latest 13F filing (Q3 2026), DAVENPORT & Co LLC reduced its position in ELV. The position peaked in Q3 2025 at 630.20K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.